Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7939563 | 0.89 | UGT2B7 (0.49) | UGT2B7CETP | |
| SCHEMBL7940649 | 0.89 | UGT2B7 (0.49) | UGT2B7CETP | |
| Propanol SCHEMBL1942397 | 0.87 | UGT2B7 (0.36) | UGT2B7CETP | |
| SCHEMBL4666688 | 0.83 | UGT2B7 (0.47) | UGT2B7CETP | |
| SCHEMBL14993455 | 0.83 | UGT2B7 (0.47) | UGT2B7CETP | |
| SCHEMBL14142960 | 0.83 | UGT2B7 (0.47) | UGT2B7CETP | |
| SCHEMBL3661078 | 0.81 | PTPN1 (0.37) | UGT2B7 | |
| Propanol SCHEMBL27200262 | 0.81 | UGT2B7 (0.34) | UGT2B7 | |
| SCHEMBL3661700 | 0.78 | CYP1A2 (0.38) | UGT2B7 | |
| SCHEMBL10426293 | 0.78 | UGT2B7 (0.32) | UGT2B7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770618-B2 | ORGANOLEPTIC; PLANT EXTRACTS; MIXTURES | TAKASAGO INTERNATIONAL CORP. (JP) | 2004-08-03 | — | — | US | disclosed |
| US-20020042356-A1 | (1S,6R)-2,2,6-Trimethylcyclohexyl methyl ketone and/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone, process for producing the same, and perfume composition containing the same | TAKASAGO INTERNATIONAL CORP. (JP) | 2002-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042356-A1 | (1S,6R)-2,2,6-Trimethylcyclohexyl methyl ketone and/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone, process for producing the same, and perfume composition containing the same | MINK1, TEKT1, TMT1A | UGT2B7 3014/4885MAPT 137/4885CETP 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.